Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Consolidated Pharmaceutical Industries (CPI) is a leading pharmaceutical manufacturer based in Sudan, specializing in the production of a wide range of generic medicines and healthcare products. Established in 2008 and now a core subsidiary of the Consolidated Company Limited group, CPI operates a large-scale manufacturing facility in the Soba Industrial Area of Khartoum. The company's extensive portfolio includes over 210 products across 12 therapeutic categories, such as anti-infectives, cardiovascular treatments, and oncology drugs. CPI is recognized for its commitment to international quality standards and plays a vital role in the regional healthcare ecosystem by providing affordable and accessible medications. The company also provides contract manufacturing services and is expanding its capabilities into injectables and intravenous fluids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Consolidated Pharmaceutical.